FH is a genetic condition of very high cholesterol levels that presents a high risk for coronary artery disease.

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with ...

The dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk ...

A simple scoring system could revolutionize how doctors prevent heart attacks and strokes by identifying patients most likely ...

Heart disease is more common in people over 65, but treatments are better than ever. That can complicate decision-making for older heart patients.

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

"Later that day, I had a phone call to say that I had had a heart attack and that they were expecting me in A&E. I spent five ...

Study led by Mount Sinai researcher shows sotagliflozin is the only drug in its class to demonstrate these results ...

Groundbreaking research reveals how common diabetes medications might offer unprecedented protection against heart attacks ...

Levy leads a team of about 40 physicians in the adult cardiology program at Memorial Healthcare System in southern Broward ...

Oxytocin, known as the “love hormone,” is released in the brain through physical contact such as hugging, kissing, sex, and ...

The most common formulation of birth control pills has been linked to a doubling of relative risk of heart attack and stroke, ...